Holdright D R
Department of Cardiology, Middlesex Hospital, London.
Br J Hosp Med. 1997;57(11):552-6.
In the last 2 years there has been considerable controversy over the safety of certain calcium antagonists. This article discusses recent drug developments, summarizes the publications that sparked the controversy, highlights results of the l latest trials of calcium antagonists and considers the range of clinical conditions in which calcium antagonists may play a useful role.
